Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575)
Honn, K.V.; Meyer, J.; Neagos, G.; Henderson, T.; Westley, C.; Ratanatharathorn, V.
Progress in Clinical and Biological Research 89: 295-331
1982
ISSN/ISBN: 0361-7742 PMID: 7051034 Document Number: 195391
Document emailed within 1 workday
Related Documents
Mehta, J.; Mehta, P.; Lawson, D.L.; Ostrowski, N.; Brigmon, L. 1985: Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides Journal of Laboratory and Clinical Medicine 106(3): 246-252Cerletti, C.; Chiabrando, C.; Fanelli, R.; de Gaetano, G. 1984: Is immunoreactive 6-keto-PGF1 alpha measured in serum after treatment with thromboxane-synthetase inhibitors an index of prostacyclin synthesis? Lancet 1(8383): 967-968
Chiabrando, C.; Broggini, M.; Castelli, M.G.; Cozzi, E.; Castagnoli, M.N.; Donelli, M.G.; Garattini, S.; Giavazzi, R.; Fanelli, R. 1987: Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor Cancer Research 47(4): 988-991
Basevich, V.V.; Mevkh, A.T.; Varfolomeev, S.D. 1984: Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets Biokhimiia 49(9): 1538-1545
Smith, J.B. 1987: Pharmacology of thromboxane synthetase inhibitors Federation Proceedings 46(1): 139-143
Nizankowski, R.; Krzanowski, M.; Musiał, J.; Szczeklik, A. 1991: Effect of thromboxane A2 synthetase inhibitor and prostacyclin analogue on arterial blood pressure, fibrinolysis and platelet function in patients with hypertension Polski Tygodnik Lekarski 46(1-3): 18-21
Madan, Z.M.; Sainani, G.S. 2000: Effects of cyclo-oxygenase and thromboxane synthetase inhibitors on right atrial prostaglandins Journal of the Association of Physicians of India 48(6): 581-583
Nakayama, D.; Ikeda, T. 1988: Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat Nihon Jinzo Gakkai Shi 30(1): 79-84
De Clerck, F.; Beetens, J.; de Chaffoy de Courcelles, D.; Vercammen, E.; Freyne, E.; Janssen, P.A. 1989: R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule Progress in Clinical and Biological Research 301: 567-572
Wilkes, B.M.; Hollander, A.M.; Sung, S.Y.; Mento, P.F. 1992: Cyclooxygenase inhibitors blunt thromboxane action in human placental arteries by blocking thromboxane receptors American Journal of Physiology 263(4 Pt 1): E718-E723
Golino, P.; Ambrosio, G.; Gresele, P.; Pascucci, I.; Ragni, M.; Russolillo, E.; Leproux, G.B.; Chiariello, M. 1993: The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade Journal of Pharmacology and Experimental Therapeutics 266(2): 511-517
Weber, A.A.; Schrör, K. 1998: Complex control of vascular smooth muscle cell growth by thromboxane A2 Thrombosis and Haemostasis 80(1): 207-208
Warren, P.; Song, W.; Holle, E.; Holmes, L.; Wei, Y.; Li, J.; Wagner, T.; Yu, X. 2002: Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice Anticancer Research 22(2a): 599-604
Zhao, W.G.; Richardson, J.S. 1990: Prostacyclin, thromboxane A2, and hypertension Clinical and Investigative Medicine. Medecine Clinique et Experimentale 13(6): 343-352
Yamaguchi, K.; Ogawa, K.; Katsube, T.; Shimao, K.; Konno, S.; Shimakawa, T.; Yoshimatsu, K.; Naritaka, Y.; Yagawa, H.; Hirose, K. 2005: Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis Anticancer Research 25(2a): 847-851
Tsuruo, T. 1987: Tumor-induced platelet aggregation and growth-promoting factors as determinants of probable tumor metastasis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(6 Part 2): 2033-2039
Gliniak, B.; Le, T. 1999: Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11 Cancer Research 59(24): 6153-6158
Tsuruo, T.; Oh-hara, T.; Iida, H.; Tsukagoshi, S.; Sato, Z.; Matsuda, I.; Iwasaki, S.; Okuda, S.; Shimizu, F.; Sasagawa, K. 1986: Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines Cancer Research 46(1): 381-385
Röth, E.; Kelemen, D.; Török, B.; Nagy, A.; Pollak, S. 1989: Dynamics of prostacyclin and thromboxane during myocardial ischemia Progress in Clinical and Biological Research 308: 907-911
Shen, X.Y. 1984: Changes of thromboxane A2 and prostacyclin in the pregnant hypertensive syndrome Zhonghua Yi Xue Za Zhi 64(12): 735